Concentrix shares have fallen about 84.8% over the past five years, yet the stock now trades at a price-to-sales ratio of roughly 0.1x, well below the industry average of 0.9x and a Simply Wall St fair P/S estimate of 0.7x. The company screens as undervalued in five of six areas on Simply Wall St's broader valuation checks, suggesting the current market price leans cheap against several fundamental measures. Recent news around expanding iX Suite contracts and strong cash generation support the earnings and cash flow story, while a weaker outlook and reduced growth expectations may keep pressure on the multiple. The key question is whether the discount reflects overdone pessimism or a fair handicap on integration, growth and guidance risks.
Concentrix CorporationStock trades at 0.1x P/S vs industry 0.9x and fair value 0.7x, flagged as undervalued on multiple checks.